Speaker illustration

Doctor Takahito Doi

Herlev Hospital, Herlev (Denmark)

MD, PhD Takahito Doi is a fully trained cardiologist and a researcher within cardiovascular sciences. He finished his clinical cardiology training at the National Cerebral and Cardiovascular Center, Osaka in Japan in 2018, and subsequently obtained his PhD with honor from Tohoku University in Japan in 2019. He has continued his interest in the pathogenesis, diagnosis, and treatment of atherosclerotic cardiovascular disease including myocardial infarction. Moreover, his special interest is on familial hypercholesterolemia and coronary artery ectasia, in both of which myocardial infarction occurs. He is currently pursuing his research focusing on remnant cholesterol and cardiovascular disease with Prof. Borge Nordestgaard, Copenhagen in Denmark, who chairs the Copenhagen General Population Study.

Explanations for contrasting results of REDUCE-IT vs. STRENGTH

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids

Session: Late Breaking Science in Prevention


Sex-related differences in clinical characteristics, low-density lipoprotein cholesterol control and cardiovascular outcomes in familial hypercholesterolemia.

Event: ESC Congress 2017

Topic: Lipids (Epidemiology and Prevention)

Session: Lipids


Coronary artery ectasia associates with future cardiac events in patients with acute myocardial infarction.

Event: ESC Congress 2016

Topic: Post infarction period

Session: Long-term out come after myocardial infarction


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb